Notice of Effectiveness
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: February 8, 2023
Accession Number: 0001437749-23-002488
Submission Type: POS AM
CIK: 0001833214
Company Name: SAB Biotherapeutics, Inc.
File Number: 333-261496